Clinical Research Directory
Browse clinical research sites, groups, and studies.
Back to Studies
COMPLETED
NCT07944768
NA
Optimal Induction Agent in Hemodynamically Unstable Patients Undergoing Emergency Surgery: A Comparative Study Between Ketamine and Etomidate With or Without Midazolam
Sponsor: Al-Azhar University
View on ClinicalTrials.gov
Summary
This work aimed to assess the hemodynamic effects of ketamine versus etomidate with or without midazolam as induction agents in patients undergoing emergency surgery.
Key Details
Gender
All
Age Range
18 Years - 75 Years
Study Type
INTERVENTIONAL
Enrollment
120
Start Date
2024-07-01
Completion Date
2025-02-01
Last Updated
2026-11-18
Healthy Volunteers
No
Interventions
DRUG
Ketamine
Patients received intravenous ketamine 2 mg/kg.
DRUG
Etomidate
Patients received etomidate 0.3 mg/kg.
DRUG
Ketamine + Midazolam
Patients received ketamine 1.5 mg/kg and midazolam 2 mg.
DRUG
Etomidate + Midazolam
Patients received etomidate 0.2 mg/kg and midazolam 2 mg.
Locations (1)
Al-Azhar University
Damietta, Egypt